EGR1 and breast carcinoma: Collectively, these results indicate that breast cancer cells may utilize CTCF and EGR1 to drive Nm23-H1 expression and suppress the invasive phenotype, whereas the downregulation of these proteins in aggressive breast cancers potentially contribute to cancer metastasis.